Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study

Elizabeth M. Swisher; Carol Aghajanian; David M. O'Malley; Gini F. Fleming; Scott H. Kaufmann; Douglas A. Levine; Michael J. Birrer; Kathleen N. Moore; Nick M. Spirtos; Mark S. Shahin; Thomas J. Reid; Michael Friedlander; Karina Dahl Steffensen; Aikou Okamoto; Vasudha Sehgal; Peter J. Ansell; Minh H. Dinh; Michael A. Bookman; Robert L. Coleman

doi:10.1097/01.ogx.0000827620.82650.68

Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study

Elizabeth M. Swisher, Carol Aghajanian, David M. O'Malley, Gini F. Fleming, Scott H. Kaufmann, Douglas A. Levine, Michael J. Birrer, Kathleen N. Moore, Nick M. Spirtos, Mark S. Shahin, Thomas J. Reid, Michael Friedlander, Karina Dahl Steffensen, Aikou Okamoto, Vasudha Sehgal, Peter J. Ansell, Minh H. Dinh, Michael A. Bookman, Robert L. Coleman

Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	277-278
Number of pages	2
Journal	Journal of Bone and Joint Surgery
Volume	77
Issue number	5
DOIs	https://doi.org/10.1097/01.ogx.0000827620.82650.68
State	Published - May 1 2022

ASJC Scopus subject areas

Surgery
Orthopedics and Sports Medicine

Access to Document

10.1097/01.ogx.0000827620.82650.68

Cite this

Swisher, E. M., Aghajanian, C., O'Malley, D. M., Fleming, G. F., Kaufmann, S. H., Levine, D. A., Birrer, M. J., Moore, K. N., Spirtos, N. M., Shahin, M. S., Reid, T. J., Friedlander, M., Steffensen, K. D., Okamoto, A., Sehgal, V., Ansell, P. J., Dinh, M. H., Bookman, M. A., & Coleman, R. L. (2022). Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study. Journal of Bone and Joint Surgery, 77(5), 277-278. https://doi.org/10.1097/01.ogx.0000827620.82650.68

Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study. / Swisher, Elizabeth M.; Aghajanian, Carol; O'Malley, David M. et al.
In: Journal of Bone and Joint Surgery, Vol. 77, No. 5, 01.05.2022, p. 277-278.

Research output: Contribution to journal › Comment/debate › peer-review

Swisher, EM, Aghajanian, C, O'Malley, DM, Fleming, GF, Kaufmann, SH, Levine, DA, Birrer, MJ, Moore, KN, Spirtos, NM, Shahin, MS, Reid, TJ, Friedlander, M, Steffensen, KD, Okamoto, A, Sehgal, V, Ansell, PJ, Dinh, MH, Bookman, MA & Coleman, RL 2022, 'Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study', Journal of Bone and Joint Surgery, vol. 77, no. 5, pp. 277-278. https://doi.org/10.1097/01.ogx.0000827620.82650.68

@article{3454417e942846b29caf4dafb40fe1b9,

title = "Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study",

author = "Swisher, {Elizabeth M.} and Carol Aghajanian and O'Malley, {David M.} and Fleming, {Gini F.} and Kaufmann, {Scott H.} and Levine, {Douglas A.} and Birrer, {Michael J.} and Moore, {Kathleen N.} and Spirtos, {Nick M.} and Shahin, {Mark S.} and Reid, {Thomas J.} and Michael Friedlander and Steffensen, {Karina Dahl} and Aikou Okamoto and Vasudha Sehgal and Ansell, {Peter J.} and Dinh, {Minh H.} and Bookman, {Michael A.} and Coleman, {Robert L.}",

year = "2022",

month = may,

day = "1",

doi = "10.1097/01.ogx.0000827620.82650.68",

language = "English (US)",

volume = "77",

pages = "277--278",

journal = "Journal of Bone and Joint Surgery",

issn = "0021-9355",

publisher = "Journal of Bone and Joint Surgery Inc.",

number = "5",

}

TY - JOUR

T1 - Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study

AU - Swisher, Elizabeth M.

AU - Aghajanian, Carol

AU - O'Malley, David M.

AU - Fleming, Gini F.

AU - Kaufmann, Scott H.

AU - Levine, Douglas A.

AU - Birrer, Michael J.

AU - Moore, Kathleen N.

AU - Spirtos, Nick M.

AU - Shahin, Mark S.

AU - Reid, Thomas J.

AU - Friedlander, Michael

AU - Steffensen, Karina Dahl

AU - Okamoto, Aikou

AU - Sehgal, Vasudha

AU - Ansell, Peter J.

AU - Dinh, Minh H.

AU - Bookman, Michael A.

AU - Coleman, Robert L.

PY - 2022/5/1

Y1 - 2022/5/1

UR - http://www.scopus.com/inward/record.url?scp=85130778239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85130778239&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000827620.82650.68

DO - 10.1097/01.ogx.0000827620.82650.68

M3 - Comment/debate

AN - SCOPUS:85130778239

SN - 0021-9355

VL - 77

SP - 277

EP - 278

JO - Journal of Bone and Joint Surgery

JF - Journal of Bone and Joint Surgery

IS - 5

ER -

Impact of Homologous Recombination Status and Responses with Veliparib Combined with First-Line Chemotherapy in Ovarian Cancer in the Phase 3 VELIA/GOG-3005 Study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this